A Comparative Study on the Efficacy and Safety of Autologous Serum Therapy versus Azathioprine in the Treatment of Chronic Spontaneous Urticaria at a Tertiary Healthcare Centre in Uttar Pradesh
Article Information
Publication Timeline
- Received26 May 2026
- Accepted24 June 2026
- Published
Abstract
Background: Chronic spontaneous urticaria (CSU) is a common inflammatory dermatosis characterised by recurrent wheals, pruritus, and angioedema persisting for six weeks or longer without an identifiable trigger. A substantial proportion of patients remain symptomatic despite standard antihistamine therapy, necessitating immunomodulatory alternatives such as autologous serum therapy (AST) and azathioprine.
Objective: To compare the efficacy and safety of AST and azathioprine in patients with CSU attending a tertiary healthcare centre in Uttar Pradesh.
Methods: In this prospective, interventional study, 60 patients with CSU aged 18–60 years were randomly allocated to two groups of 30. Group A received weekly intramuscular autologous serum injections for 9 weeks; Group B received oral azathioprine 50 mg/day for 12 weeks. Disease severity was quantified using the Total Severity Score (TSS) at baseline and at 4, 8, and 12 weeks. Clinical response, autologous serum skin test (ASST) status, antihistamine requirement, and adverse events were recorded.
Results: Baseline characteristics were comparable between groups (p > 0.05). Mean TSS fell from 13.3 ± 2.1 to 5.6 ± 1.8 in the AST group (57.8% reduction) and from 14.2 ± 1.9 to 3.4 ± 1.6 in the azathioprine group (76.1% reduction) at 12 weeks (p < 0.001). Total response rate was 73.3% with AST versus 83.4% with azathioprine, with complete remission in 23.3% and 46.7% of patients respectively (p = 0.038). ASST-positive status, shorter disease duration, absence of angioedema, younger age, and female sex were associated with better outcomes. Both therapies were well tolerated; no serious adverse events or treatment discontinuations occurred.
Conclusion: Azathioprine produced faster and more complete symptom control, whereas AST offered a safe, low-cost, minimally invasive alternative with a simpler monitoring burden. Treatment selection in CSU should be individualised according to disease severity, ASST status, comorbidity, and resource availability.
Keywords
Chronic spontaneous urticariaAutologous serum therapyAzathioprineTotal severity scoreAutologous serum skin testReferences
- Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M. Autoimmune chronic spontaneous urticaria: what we know and what we do not know. J Allergy Clin Immunol. 2017;139(6):1772-81. [Google Scholar][Crossref]
- Caffarelli C, Cuomo B, Cardinale F, Barberi S, Dascola CP, Agostinis F, et al. Aetiological factors associated with chronic urticaria in children: a systematic review. Acta Derm Venereol. 2013;93:268-72. [Google Scholar][Crossref]
- Ben-Shoshan M, Blinderman I, Raz A. Psychosocial factors and chronic spontaneous urticaria: a systematic review. Allergy. 2013;68(2):131-41. [Google Scholar][Crossref]
- Kaplan A, Lebwohl M, Giménez-Arnau AM, Hide M, Armstrong AW, Maurer M. Chronic spontaneous urticaria: focus on pathophysiology to unlock treatment advances. Allergy. 2023;78(2):389-401. [Google Scholar][Crossref]
- Saini SS. Chronic spontaneous urticaria: etiology and pathogenesis. Immunol Allergy Clin North Am. 2014;34(1):33-52. [Google Scholar][Crossref]
- Saini SS, Asero R, Cugno M, Park HS, Oliver ET. Pathogenesis of chronic spontaneous urticaria with or without angioedema. J Allergy Clin Immunol Pract. 2025;13(9):2221-8. [Google Scholar][Crossref]
- Gonçalo M, Gimenéz-Arnau A, Al-Ahmad M, Ben-Shoshan M, Bernstein JA, Ensina LF, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021;184(2):226-36. [Google Scholar][Crossref]
- Soong W, Patil D, Rodrigues J, Kohli RK, Krupsky K, Gupta S, et al. Clinical profile, prevalence, and burden of chronic spontaneous urticaria in the United States. World Allergy Organ J. 2025;18(8):101081. [Google Scholar][Crossref]
- Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77:734-66. [Google Scholar][Crossref]
- Riedl MA, Patil D, Rodrigues J, Kuruvilla M, Raftery T, International Journal of Medical and All Body Health Research www.allmedicaljournal.com Pivneva I, et al. Clinical burden, treatment, and disease control in patients with chronic spontaneous urticaria: real-world evidence. Ann Allergy Asthma Immunol. 2025;134(3):324-32. [Google Scholar][Crossref]
- Johal KJ, Saini SS. Current and emerging treatments for chronic spontaneous urticaria. Ann Allergy Asthma Immunol. 2020;125(4):380-7. [Google Scholar][Crossref]
- Bajaj AK, Saraswat A, Upadhyay A, Damisetty R, Dhar S. Autologous serum therapy in chronic urticaria: old wine in a new bottle. Indian J Dermatol Venereol Leprol. 2008;74(2):109-13. [Google Scholar][Crossref]
- Yu L, Buttgereit T, Stahl Skov P, Schmetzer O, Scheffel J, Kocatürk E, et al. Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2019;33(9):1747-54. [Google Scholar][Crossref]
- Godse KV, Nadkarni N, Patil S, Mehta A. Subcutaneous autologous serum therapy in chronic spontaneous urticaria. Indian J Dermatol. 2017;62(5):505-7. [Google Scholar][Crossref]
- Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CEH. EAACI/GA²LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64:1256-68. [Google Scholar][Crossref]
- Baumann K, Marcelino J, Skov PS, Santos MC, Wyroslak I, Scheffel J, et al. Autologous serum skin test reactions in chronic spontaneous urticaria differ from heterologous cell reactions. J Eur Acad Dermatol Venereol. 2021;35(6):1338-45. [Google Scholar][Crossref]
- Kumar YH, Bhaskar S, Shankar K. Comparative study of positive versus negative autologous serum skin test in chronic spontaneous urticaria and its treatment outcome. North Am J Med Sci. 2016;8(1):25. [Google Scholar][Crossref]
- Kocatürk E, Aktaş S, Türkoğlu Z, Kavala M, Zindancı I, Koç M, et al. Autologous whole blood and autologous serum injections are equally effective as placebo injections in reducing disease activity in patients with chronic spontaneous urticaria: a placebo-controlled, randomized, single-blind study. J Dermatolog Treat. 2012;23(6):465-71. [Google Scholar][Crossref]
- Bhanja DC, Ghoshal L, Das S, Das S, Roy AK. Azathioprine in autologous serum skin test positive chronic urticaria: a case-control study in a tertiary care hospital of eastern India. Indian Dermatol Online J. 2015;6(3):185-8. [Google Scholar][Crossref]
- Tal Y, Toker O, Agmon-Levin N, Shalit M. Azathioprine as a therapeutic alternative for refractory chronic urticaria. Int J Dermatol. 2015;54(3):367-9. [Google Scholar][Crossref]
- Elazab S, Hessam W. The effect of autologous serum therapy in chronic spontaneous urticaria depends on autologous serum skin test positivity. Egypt J Immunol. 2017;24(2):165-72. [Google Scholar][Crossref]
- Valapil AP, Issac CM, Vineetha M. Autologous serum therapy in chronic idiopathic urticaria. J Evid Based Med Healthc. 2020;7(30):1453-8. [Google Scholar][Crossref]
- Wannous BI, Khaddam J, Ismaiel MA. Efficacy of autologous serum therapy in chronic urticaria: a prospective experimental cohort study. Open Dermatol J. 2022;16:e2209260. [Google Scholar][Crossref]
- Mohammed J. Autologous serum therapy reduces the symptoms and antihistamine burden in patients with chronic urticaria. Adv Dermatol Allergol. 2023;40:398-401. [Google Scholar][Crossref]
- Chu A, Oykhman P, Chu X, Rayner D, Bhangal S, Dam A, et al. Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: systematic review and network meta-analysis. J Allergy Clin Immunol. 2025;156(4):1008-23. [Google Scholar][Crossref]
How to Cite
Cherishma, G., Saxena, D., Kumar, S., Sharma, D. R., & Danish, M. (2026). A Comparative Study on the Efficacy and Safety of Autologous Serum Therapy versus Azathioprine in the Treatment of Chronic Spontaneous Urticaria at a Tertiary Healthcare Centre in Uttar Pradesh. International Journal of Medical and All Body Health Research, 7(3), 121-126. https://doi.org/10.54660/IJMBHR.2026.7.3.121-126
Cherishma, Gavvala, et al. "A Comparative Study on the Efficacy and Safety of Autologous Serum Therapy versus Azathioprine in the Treatment of Chronic Spontaneous Urticaria at a Tertiary Healthcare Centre in Uttar Pradesh." International Journal of Medical and All Body Health Research, vol. 7, no. 3, 2026, pp. 121-126. https://doi.org/10.54660/IJMBHR.2026.7.3.121-126.
Cherishma, G., Saxena, D., Kumar, S., Sharma, D. R. and Danish, M. (2026) 'A Comparative Study on the Efficacy and Safety of Autologous Serum Therapy versus Azathioprine in the Treatment of Chronic Spontaneous Urticaria at a Tertiary Healthcare Centre in Uttar Pradesh', International Journal of Medical and All Body Health Research, 7(3), pp. 121-126. doi: 10.54660/IJMBHR.2026.7.3.121-126.
Cherishma G, Saxena D, Kumar S, Sharma DR, Danish M. A Comparative Study on the Efficacy and Safety of Autologous Serum Therapy versus Azathioprine in the Treatment of Chronic Spontaneous Urticaria at a Tertiary Healthcare Centre in Uttar Pradesh. International Journal of Medical and All Body Health Research. 2026;7(3):121-126. doi:10.54660/IJMBHR.2026.7.3.121-126
Similar Articles
- Risk Factors of Increasing Intra-Abdominal Pressure and Compartment Syndrome and Their Management in Post Emergency Laparotomies’ Patients Vol 7, Issue 3 (2026)
- Assessment of Carpal Tunnel Syndrome (Cts) In Patients with Rheumatoid Arthritis in Basrah, South of Iraq Vol 7, Issue 3 (2026)
- Predictive Pre-Cancerous Biomarkers in BRCA1/2 Mutation Carriers: From Tissue-Resident Pre-CAFs to Blood-Based Exosomal Cargo Vol 7, Issue 3 (2026)
- Current Trends of Genital Tuberculosis Among Infertile Females Attending a Tertiary Care Centre: A Prevalence and Clinico-Histopathological Study Vol 7, Issue 3 (2026)
- Effect of Implementing a Blood Group Matching Program for Rh (D, C, c, E, e) and Kell on Biochemical and Hematological Parameters in Beta Thalassemia Patients (βT) Vol 7, Issue 3 (2026)
Find this Article on
Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASEA newly published article may take a few days to appear on these services.